GSC
BSX icon

Grey Street Capital’s Boston Scientific BSX Stock Holding History

Grey Street Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$871K Buy
+12,710
New +$817K 0.12% 199

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Grey Street Capital's BSX Position: Q1 2024 in Review

Grey Street Capital opened a new position in Boston Scientific (BSX) in Q1 2024: 12,710 shares worth $871K. The stake represents 0.12% of the portfolio and ranks #199 among its holdings.

1,225 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

  • Grey Street Capital held 12,710 shares of Boston Scientific worth $871K as of Q1 2024.
  • Boston Scientific was a new Grey Street Capital position in Q1 2024.
  • Boston Scientific made up 0.12% of Grey Street Capital's portfolio in Q1 2024, its #199 holding.
  • 1,225 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Grey Street Capital's 13F filing for Q1 2024, filed 9 Aug 2024.